BUY SIDE BRO

AXS Brendan Wood TopGun Index ETF TGN

Latest Deep Dive · Written · AI research note

Bro's Verdict
Deep Dive

Rating

HOLD

Confidence

30%

Target Price

$0.24

Upside

+0.0%

Horizon

medium

The analysis explicitly assigns no price target and states fair value cannot be derived with confidence, since TGN has no revenue, earnings, disclosed cash or resource NAV inputs — the equity is a binary option on FID, funding and permitting. With the recommendation framed as conditional and the absence of a defensible valuation anchor, the appropriate stance is HOLD rather than a directional call. Risk-tolerant capital may see high torque from the US listing and Watershed FID, but the dilution risk of a pre-revenue developer argues for waiting until funding and offtake terms are confirmed.

Executive Summary

•TGN (Tungsten Mining NL) is a pre revenue critical minerals developer, so the investment case rests on resource scale, development funding and offtake, not current cash flows.
•The flagship Mt Mulgine asset, 100% owned, is one of the largest undeveloped tungsten deposits outside China, giving pure play exposure to a supply constrained critical mineral.
•A pursued US listing and fresh institutional backing toward the Watershed development signal a shift from exploration narrative toward financing and construction.
•Valuation is binary and event driven: the equity is a call option on funding, permitting and first production, with H1 2027 flagged as a potential production target at Watershed.

Financial Snapshot

•Revenue: nil (pre revenue developer)
•EPS: negative (Not disclosed, no earnings base)
•Net margins: not applicable, no revenue
•Cash position: Not disclosed in available data
•Debt: Not disclosed
•Share price: ~A$0.245
•Market cap: Not disclosed
•Production status: pre production, targeting potential H1 2027 at Watershed

Forward Outlook

•Revenue guidance: none issued, no production until at least H1 2027 on current timelines
•EPS estimates: Not disclosed, no consensus earnings base for a pre revenue developer
•Margin trajectory: not applicable until first production and offtake pricing are established
•Capital raising: fresh institutional backing reported, quantum Not disclosed
•Corporate action: US listing being pursued, timing Not disclosed
•Development milestone: Watershed advancing toward a final investment decision (FID)

Valuation Analysis

•NTM P/E: not applicable, no forward earnings
•NTM P/S: not applicable, no forward revenue
•NTM EV/EBIT: not applicable, no forward EBIT
•Valuation must be framed on resource based net asset value (NAV), not earnings multiples
•NAV per share: Not disclosed, requires resource tonnage, grade and recovery assumptions
•Peer comparison is constrained by the absence of listed tungsten pure plays of comparable scale
•EQ Resources: tungsten exposure via the Springer Tungsten Complex, Nevada, alongside Blue Moon and Elmet Group in a US$150-175m investment
•The Springer transaction is a useful read across for the scale of capital now flowing into Western tungsten supply
•Fair value: cannot be derived with confidence from available data; treat as a development stage optionality play
•Implied upside is contingent on FID, funding and permitting rather than on multiple re rating

Key Risks & Catalysts

Risks

•Pre revenue status means ongoing dilution risk from equity raisings to fund development
•Tungsten prices are opaque and China influenced, limiting pricing visibility
•Permitting and approvals for Mt Mulgine and Watershed carry timing risk
•FID may slip beyond current H1 2027 production targets
•No disclosed cash position or funding runway in available data
•Single asset concentration in Mt Mulgine
•Junior resource equities are highly illiquid and volatile

Catalysts

•Final investment decision at Watershed
•Completion of the pursued US listing, which could broaden the investor base
•Offtake agreements with defence, aerospace or electronics buyers
•Updated resource or feasibility numbers for Mt Mulgine
•Further institutional backing or strategic investment
•Continued Western government support for critical minerals supply chains

Investment Thesis

TGN is a development stage critical minerals play, not an earnings story. The thesis hinges on Mt Mulgine being one of the largest undeveloped tungsten deposits outside China, with 100% ownership giving full exposure to development and offtake as Western governments and defence supply chains look to reduce reliance on Chinese tungsten. The pursued US listing and reported institutional backing toward Watershed suggest management is positioning for a financing and construction phase rather than pure exploration.

The problem for a valuation driven investor is that almost none of the usual frameworks apply. With no revenue, no earnings and no disclosed cash or funding runway, NTM P/E, NTM P/S and NTM EV/EBIT are all not applicable. Fair value has to be built from a resource based NAV, and that requires tonnage, grade and recovery assumptions that are Not disclosed here. Until those inputs and a funding plan are visible, the equity is best treated as a binary option on FID and permitting.

Recommendation is therefore conditional, and no price target is assigned given the missing data. For risk tolerant capital, TGN offers high torque exposure to a genuine critical minerals theme, with the US listing and Watershed FID as the near term triggers. For the core portfolio, the absence of a defensible valuation anchor and the dilution risk of a pre revenue developer argue for waiting until funding and offtake terms are confirmed. Key monitorables are the FID outcome, the US listing terms and any offtake announcement.

Written by Buy Side Bro's AI analyst from financials, consensus, filings and recent news. General information only, not financial advice.

Run your own analysis free

Buy Side Bro writes a note like this on any US, ASX or global stock in a few minutes: the thesis, valuation, catalysts, risks and a Buy, Hold or Sell call with a 12-month target. It comes with the daily market wrap, live markets, earnings and charts. Sign in and you get 7 days of full access free, no card needed.

iPhone app coming soon. The same account and subscription carry over.

See the latest research on other stocks